Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)
This study has been completed.
National Institutes of Health (NIH)
Information provided by (Responsible Party):
First received: February 13, 2009
Last updated: November 21, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2010|
|Primary Completion Date:||October 2010 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||November 20, 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Mytle N, Hopkins RJ, Malkevich NV, Basu S, Meister GT, Sanford DC, Comer JE, Van Zandt KE, Al-Ibrahim M, Kramer WG, Howard C, Daczkowski N, Chakrabarti AC, Ionin B, Nabors GS, Skiadopoulos MH. Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. Antimicrob Agents Chemother. 2013 Nov;57(11):5684-92. doi: 10.1128/AAC.00458-13.